About: Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 08 February 2010

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2010 (fr) наукова стаття, опублікована в лютому 2010 (uk) scientific article published on 08 February 2010 (en) artículu científicu espublizáu en febreru de 2010 (ast)
publication date	wds:Q82832675-74288E3A-5282-4BB2-89C9-D154C748D009
publication date	2010-02-08 00:00:00Z (xsd:dateTime)
author name string	wds:Q82832675-43E37BDA-455E-4490-9E0B-C38D5277BC0C wds:Q82832675-484B0F5F-AF75-45D0-A039-9A8587F8F1A3
author name string	O Klepp R M Bremnes
rdfs:label	Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (en) Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (nl)
skos:prefLabel	Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (en) Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (nl)
name	Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (en) Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (nl)
author	wds:Q82832675-06BA58D4-A4F9-40D2-B78C-FCDD265D60B3 wds:Q82832675-359053C1-9691-4D3A-8EEE-C274683B931A wds:Q82832675-3C74542F-3CA0-4495-B0B2-95BD939E34BC wds:Q82832675-8D7B1F16-2227-41F4-A66D-89729AB64564 wds:Q82832675-EF909990-C5B7-45E0-84D7-341378EA101C
author	Eva Cavallin-Ståhl Olav Dahl Gabriella Cohn-Cedermark Torgrim Tandstad U Stierner
title	wds:Q82832675-21AABA86-ACAB-47FA-BF5F-0579F8FD8D3C
title	Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study (en)
page(s)	wds:Q82832675-43E0EC14-8B14-4EEF-BCD0-0DE4C20B3A6B
page(s)	1858-1863
instance of	wds:Q82832675-0F966679-BC7F-43D6-B892-15626AC87ED3
instance of	scholarly article
main subject	wds:Q82832675-BA6F640F-380B-407F-B759-A6AD9D42E7E8
main subject	testicular cancer
PubMed ID	wds:Q82832675-4C19DA30-F75F-4CB2-951F-018C1EA94F54
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20142410
PubMed ID	20142410
published in	wds:Q82832675-89EB3E1C-D81E-4955-9A46-D5009C960AF5
published in	Annals of Oncology
issue	wds:Q82832675-2D3EF9D7-86E6-4C91-A0F6-F48491627063
volume	wds:Q82832675-DFCF9B54-08DD-4559-A10C-7D813E1166BB
issue	9
volume	21
DOI	wds:Q82832675-7C43458B-C927-4B8E-AB75-7C63C41AEAC7
DOI	http://dx.doi.org/10.1093/ANNONC/MDQ026
DOI	10.1093/ANNONC/MDQ026
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q82832675
is cites work of	Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Management trends for men with early-stage nonseminomatous germ cell tumors of the testicle: An analysis of the National Cancer Database Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era. Surgical management of late relapse on surveillance in patients presenting with clinical stage I testicular cancer. Testicular microlithiasis: recent advances in understanding and management Advances in the treatment of testicular cancer MicroRNAs as Biomarkers for Germ Cell Tumors Current Concepts in Management of Stage I NSGCT. Decision analysis defining optimal management of clinical stage 1 high-risk nonseminomatous germ cell testicular cancer with lymphovascular invasion
is cites work of	wds:Q39391858-1E79052F-E34A-4EAE-A029-C2041953DDF7 wds:Q41040049-5CA85682-9D2C-419B-B9D0-840C2735B4A4 wds:Q50628714-A9EDC3B3-BE8E-48ED-8906-1D07D453F4A2 wds:Q26773626-82F4A4AC-E16C-4C40-B7B8-B3F4C9B50380 wds:Q37851834-7F1FCACB-9C98-427C-8751-CDE07B8E0312 wds:Q43223621-1F847932-9324-44A4-8CFF-955E68F3CCF4 wds:Q39105754-62676919-C99E-402A-AD95-D7867D673103 wds:Q88653687-9C9A351A-C417-4666-A591-59E3953F752D wds:Q91660940-91DD7207-2A95-4448-8B93-4CCE41868F0A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 169 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software